Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind placebo-controlled study of SB681323 in neuropathic pain following nerve trauma
2006-001072-21Phase 2Completed
- Sponsor
- GSK
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Neuralgia comparing SB681323 with Placebo (2 arms). Primary endpoint: Average daily pain score Weeks 1–2. Started Aug 2007; status: completed.
02
Drugs
dilmapimod
03
Conditions
Neuralgia
Beyond the preview
Go deeper on 2006-001072-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001072-21.